AP9801290A0 - Phar aceut cal c mposi ions ontaining eletriptan hemisulphate - Google Patents

Phar aceut cal c mposi ions ontaining eletriptan hemisulphate

Info

Publication number
AP9801290A0
AP9801290A0 AP9801290A AP9801290A AP9801290A0 AP 9801290 A0 AP9801290 A0 AP 9801290A0 AP 9801290 A AP9801290 A AP 9801290A AP 9801290 A AP9801290 A AP 9801290A AP 9801290 A0 AP9801290 A0 AP 9801290A0
Authority
AP
ARIPO
Prior art keywords
aceut
mposi
ontaining
phar
cal
Prior art date
Application number
AP9801290A
Other versions
AP1100A (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of AP9801290A0 publication Critical patent/AP9801290A0/en
Application granted granted Critical
Publication of AP1100A publication Critical patent/AP1100A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Packaging Of Annular Or Rod-Shaped Articles, Wearing Apparel, Cassettes, Or The Like (AREA)
APAP/P/1998/001290A 1997-07-03 1998-07-02 Pharaceutical compositions containing eletriptan hemisulphate. AP1100A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9714081.8A GB9714081D0 (en) 1997-07-03 1997-07-03 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
AP9801290A0 true AP9801290A0 (en) 1998-09-30
AP1100A AP1100A (en) 2002-09-02

Family

ID=10815339

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1998/001290A AP1100A (en) 1997-07-03 1998-07-02 Pharaceutical compositions containing eletriptan hemisulphate.

Country Status (13)

Country Link
KR (1) KR100384346B1 (en)
AP (1) AP1100A (en)
AR (1) AR013165A1 (en)
CO (1) CO4950555A1 (en)
GB (2) GB9714081D0 (en)
GT (1) GT199800105A (en)
HN (1) HN1998000101A (en)
MY (1) MY119643A (en)
PA (1) PA8454501A1 (en)
PE (1) PE84499A1 (en)
TN (1) TNSN98126A1 (en)
UA (1) UA49955C2 (en)
ZA (1) ZA985812B (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9417310D0 (en) * 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
UA49955C2 (en) 2002-10-15
GB9718270D0 (en) 1997-11-05
MY119643A (en) 2005-06-30
PA8454501A1 (en) 2000-05-24
GT199800105A (en) 2000-01-04
CO4950555A1 (en) 2000-09-01
PE84499A1 (en) 1999-09-11
TNSN98126A1 (en) 2005-03-15
AR013165A1 (en) 2000-12-13
ZA985812B (en) 2000-01-10
HN1998000101A (en) 1999-01-08
KR100384346B1 (en) 2003-05-16
GB9714081D0 (en) 1997-09-10
KR20010014366A (en) 2001-02-26
AP1100A (en) 2002-09-02

Similar Documents

Publication Publication Date Title
GB2321598B (en) Reamer
EP0980559A4 (en) Biometric certificates
PL335999A1 (en) Substituted 3-cyanoquinolines
AP2000001795A0 (en) Substituted 4-aminothiazol-2-yol
HK1016976A1 (en) Resorcinyl-triazine.
DE69723848D1 (en) 3-descladinose-2,3-anhydroerythromycin-derivate
DE59804842D1 (en) Aliphatische, emissionsarme, sinterfähige thermoplastische polyurethanformmassen
ZA987055B (en) Substituted 4-benzoylpyrazoles.
ZA987058B (en) Substituted 4-benzoylpyrazoles.
AU132545S (en) Reamer
ZA9810184B (en) New phenyl-alkyl-imidazoles
GB2322316B (en) Chuck
HK1017834A1 (en) Bodyshaper.
ZA983705B (en) Pregnan-3-ol-20-ones.
ZA987B (en) Substituted 4-benzoylpyrazoles.
GB9819420D0 (en) Novel receptor
AP9801290A0 (en) Phar aceut cal c mposi ions ontaining eletriptan hemisulphate
ZA981309B (en) 4-aminoalkoxy-1H-benzoimidazoles.
EP1083909A4 (en) hCEPR RECEPTOR
GB9811074D0 (en) Connections
ZA983795B (en) Substituted 4-benzoyl-pyrazoles.
GB9725174D0 (en) Spectrometers
IL133261A0 (en) Substituted naphthropyrans
ZA985761B (en) Substituted aryluracils
GB0022726D0 (en) Not available at present